Special Issue "Germline Pharmacogenetics of Cancer Treatment"
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (28 February 2021) | Viewed by 23375
Special Issue Editor
Interests: pharmacogenetics; oncology; taxane; peripheral neuropathy
Special Issue Information
Dear Colleagues,
The patient’s inherited germline genome can be important for determining how they process (pharmacokinetics) or respond to (pharmacodynamics) cancer treatment. This Special Issue will describe the current status of germline pharmacogenetics in oncology and report novel findings in this field. Original research articles can describe the discovery, replication, or implementation of germline cancer pharmacogenetics associations, including associations with drug pharmacokinetics, treatment efficacy or toxicity. Review articles describing the current state of knowledge of pharmacogenetic associations in oncology or their clinical implementation are also welcome.
Dr. Daniel L. Hertz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenetics
- germline
- pharmacokinetics
- efficacy
- toxicity